SK83697A3 - Piperazine-2,5-dione derivatives as modulators of multi-drug resistance - Google Patents
Piperazine-2,5-dione derivatives as modulators of multi-drug resistance Download PDFInfo
- Publication number
- SK83697A3 SK83697A3 SK836-97A SK83697A SK83697A3 SK 83697 A3 SK83697 A3 SK 83697A3 SK 83697 A SK83697 A SK 83697A SK 83697 A3 SK83697 A3 SK 83697A3
- Authority
- SK
- Slovakia
- Prior art keywords
- phenyl
- ethyl
- dimethoxy
- isoquinolyl
- tetrahydro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9426224.3A GB9426224D0 (en) | 1994-12-23 | 1994-12-23 | Pharmaceutical compounds |
| PCT/GB1995/003027 WO1996020190A1 (en) | 1994-12-23 | 1995-12-22 | Piperazine 2,5 dione derivatives as modulators of multi-drug resistance |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK83697A3 true SK83697A3 (en) | 1998-05-06 |
Family
ID=10766589
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK836-97A SK83697A3 (en) | 1994-12-23 | 1995-12-22 | Piperazine-2,5-dione derivatives as modulators of multi-drug resistance |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0799222A1 (xx) |
| JP (1) | JPH10511384A (xx) |
| CN (1) | CN1175253A (xx) |
| AU (1) | AU698828B2 (xx) |
| BG (1) | BG101602A (xx) |
| BR (1) | BR9510410A (xx) |
| CA (1) | CA2207500A1 (xx) |
| CZ (1) | CZ190097A3 (xx) |
| FI (1) | FI972660A (xx) |
| GB (1) | GB9426224D0 (xx) |
| HU (1) | HUT77943A (xx) |
| IL (1) | IL116525A0 (xx) |
| NO (1) | NO972937L (xx) |
| NZ (1) | NZ297847A (xx) |
| PL (1) | PL320916A1 (xx) |
| SK (1) | SK83697A3 (xx) |
| TW (1) | TW358094B (xx) |
| WO (1) | WO1996020190A1 (xx) |
| ZA (1) | ZA9510909B (xx) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA979329B (en) * | 1996-10-18 | 1999-04-19 | Xenova Ltd | Pharmaceutical compounds |
| GB9717576D0 (en) * | 1997-08-19 | 1997-10-22 | Xenova Ltd | Pharmaceutical compounds |
| GB9708805D0 (en) | 1997-05-01 | 1997-06-25 | Smithkline Beecham Plc | Compounds |
| GB9810876D0 (en) | 1998-05-20 | 1998-07-22 | Smithkline Beecham Plc | Compounds |
| CA2346689A1 (en) | 1998-10-08 | 2000-04-20 | Gregor James Macdonald | Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
| IL150430A0 (en) * | 2000-01-18 | 2002-12-01 | Nereus Pharmaceuticals Inc | Cell division inhibitors and process for producing the same |
| US6693099B2 (en) | 2000-10-17 | 2004-02-17 | The Procter & Gamble Company | Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance |
| US7919497B2 (en) | 2002-08-02 | 2011-04-05 | Nereus Pharmaceuticals, Inc. | Analogs of dehydrophenylahistins and their therapeutic use |
| US7935704B2 (en) | 2003-08-01 | 2011-05-03 | Nereus Pharmaceuticals, Inc. | Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| IL166628A0 (en) | 2002-08-02 | 2006-01-15 | Nereus Pharmaceuticals Inc | Dehydrophenyl lahistins and analogs thereof and the synthesis of dehydrophenyllahistins and analogs thereof |
| US8129527B2 (en) | 2006-11-03 | 2012-03-06 | Nereus Pharmacuticals, Inc. | Analogs of dehydrophenylahistins and their therapeutic use |
| CN103396372B (zh) * | 2013-08-09 | 2015-05-20 | 中国科学院南海海洋研究所 | 一类2,5-二酮哌嗪衍生物及其制备方法和在制备抗海洋污损生物防除剂中的应用 |
| US10076518B2 (en) | 2015-03-06 | 2018-09-18 | Beyondspring Pharmaceuticals, Inc. | Method of treating a brain tumor |
| US10238650B2 (en) | 2015-03-06 | 2019-03-26 | Beyondspring Pharmaceuticals, Inc. | Method of treating cancer associated with a RAS mutation |
| MX2018000451A (es) | 2015-07-13 | 2018-05-07 | Beyondspring Pharmaceuticals Inc | Composiciones de plinabulina. |
| RU2753543C1 (ru) | 2016-02-08 | 2021-08-17 | Бейондспринг Фармасьютикалс, Инк. | Композиции, содержащие тукаресол или его аналоги |
| WO2017214052A1 (en) | 2016-06-06 | 2017-12-14 | Beyondspring Pharmaceuticals, Inc. | Composition and method for reducing neutropenia |
| WO2018129381A1 (en) | 2017-01-06 | 2018-07-12 | Beyondspring Pharmaceuticals, Inc. | Tubulin binding compounds and therapeutic use thereof |
| JP2020514412A (ja) | 2017-02-01 | 2020-05-21 | ビヨンドスプリング ファーマシューティカルズ，インコーポレイテッド | 好中球減少症の低減方法 |
| KR20200112881A (ko) | 2018-01-24 | 2020-10-05 | 비욘드스프링 파마수티컬스, 인코포레이티드. | 플리나불린의 투여를 통해 혈소판감소증을 감소시키는 조성물 및 방법 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0649410B1 (en) * | 1992-07-10 | 1997-05-02 | Laboratoires Glaxo Sa | Anilide derivatives |
| GB9217331D0 (en) * | 1992-08-14 | 1992-09-30 | Xenova Ltd | Pharmaceutical compounds |
-
1994
- 1994-12-23 GB GBGB9426224.3A patent/GB9426224D0/en active Pending
-
1995
- 1995-12-21 ZA ZA9510909A patent/ZA9510909B/xx unknown
- 1995-12-22 WO PCT/GB1995/003027 patent/WO1996020190A1/en not_active Application Discontinuation
- 1995-12-22 CN CN95197672A patent/CN1175253A/zh active Pending
- 1995-12-22 PL PL95320916A patent/PL320916A1/xx unknown
- 1995-12-22 CZ CZ971900A patent/CZ190097A3/cs unknown
- 1995-12-22 AU AU43100/96A patent/AU698828B2/en not_active Ceased
- 1995-12-22 SK SK836-97A patent/SK83697A3/sk unknown
- 1995-12-22 NZ NZ297847A patent/NZ297847A/en unknown
- 1995-12-22 JP JP8520301A patent/JPH10511384A/ja active Pending
- 1995-12-22 IL IL11652595A patent/IL116525A0/xx unknown
- 1995-12-22 BR BR9510410-0A patent/BR9510410A/pt not_active Application Discontinuation
- 1995-12-22 CA CA002207500A patent/CA2207500A1/en not_active Abandoned
- 1995-12-22 HU HU9800398A patent/HUT77943A/hu unknown
- 1995-12-22 EP EP95941797A patent/EP0799222A1/en not_active Withdrawn
- 1995-12-23 TW TW084113836A patent/TW358094B/zh active
-
1997
- 1997-06-11 BG BG101602A patent/BG101602A/xx unknown
- 1997-06-19 FI FI972660A patent/FI972660A/fi unknown
- 1997-06-23 NO NO972937A patent/NO972937L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL116525A0 (en) | 1996-03-31 |
| WO1996020190A1 (en) | 1996-07-04 |
| BG101602A (en) | 1998-02-27 |
| ZA9510909B (en) | 1996-08-30 |
| AU4310096A (en) | 1996-07-19 |
| FI972660A0 (fi) | 1997-06-19 |
| NO972937D0 (no) | 1997-06-23 |
| NO972937L (no) | 1997-06-23 |
| GB9426224D0 (en) | 1995-02-22 |
| TW358094B (en) | 1999-05-11 |
| AU698828B2 (en) | 1998-11-05 |
| EP0799222A1 (en) | 1997-10-08 |
| HUT77943A (hu) | 1998-12-28 |
| CA2207500A1 (en) | 1996-07-04 |
| JPH10511384A (ja) | 1998-11-04 |
| PL320916A1 (en) | 1997-11-10 |
| CZ190097A3 (cs) | 1998-01-14 |
| BR9510410A (pt) | 1999-09-08 |
| NZ297847A (en) | 1999-04-29 |
| FI972660A (fi) | 1997-08-22 |
| CN1175253A (zh) | 1998-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK83697A3 (en) | Piperazine-2,5-dione derivatives as modulators of multi-drug resistance | |
| ES2443127T3 (es) | Nuevos derivados tricíclicos o sales de éstos farmacéuticamente aceptables, su procedimiento de fabricación y composiciones farmacéuticas que los contienen | |
| KR101311757B1 (ko) | 2-아미노-7,8-디히드로-6ｈ-피리도［4,3-ｄ］피리미딘-5-온 | |
| KR20080006614A (ko) | 증식 질환의 치료에 유용한 ｈｓｐ90 억제제인2-아미노-퀴나졸린-5-온 | |
| JP2003505373A (ja) | ビフェニル誘導体、その製法及び薬剤としての使用 | |
| KR19990087550A (ko) | 4-아미노-피리미딘 유도체, 이 화합물을 함유한 약제, 이의용도 및 이의 제조 방법 | |
| MXPA03001725A (es) | Heterociclos biciclicos, medicamentos que contienen estos compuestos, su uso y metodos para su produccion. | |
| CN106536491B (zh) | 作为盐皮质激素受体调节剂的苯并噁嗪酮酰胺 | |
| JP6704422B2 (ja) | キナゾリン誘導体の塩およびその製造方法 | |
| WO2003099765A1 (fr) | Derive de $g(b)-alanine et utilisation correspondante | |
| KR20120089459A (ko) | 키나제 저해제로서 5,6-바이사이클릭 헤테로아릴-함유 우레아 화합물 | |
| WO2001010439A1 (fr) | Antagonistes d'amine cyclique ccr3 | |
| JPH10500425A (ja) | 薬学的なジケトピペラジン化合物 | |
| TW202003466A (zh) | 人類整合素α４β７拮抗劑 | |
| TW201105325A (en) | 3-oxo-2,3-dihydro-1H-isoindole-4-carboxamides | |
| JP2006503799A (ja) | グアニジノ化合物 | |
| JP2010504945A (ja) | キノリノン誘導体 | |
| JPWO2009041559A1 (ja) | インダゾールアクリル酸アミド化合物 | |
| TW200846330A (en) | Bicyclic heterocycles, pharmaceutical compositions containing these compounds, the use thereof and processes for the preparation thereof | |
| EP3212653A2 (en) | Active acrylamides | |
| EP0799210B1 (en) | Piperazine-2,5-dione derivatives as modulators of multidrug resistance | |
| JP2004519486A (ja) | クロマン誘導体、その製造方法及びその抗腫瘍剤としての使用 | |
| EA008623B1 (ru) | Замещённые в положении 6 индолиноновые производные, их получение и их применение в качестве лекарственных средств | |
| WO2010064737A1 (ja) | 複素環化合物およびその用途 | |
| JPH06184074A (ja) | １−アルコキシナフタレン−２−カルボキサミド誘導体、その製法並びに該誘導体を含有する医薬組成物 |